RetinalGenix Technologies (RTGN) Other Operating Expenses (2020 - 2026)

RetinalGenix Technologies has disclosed Other Operating Expenses across 7 years of filings, most recently posting $210016.0 for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $210016.0, down 9.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (down 8.14% YoY), and the FY2025 annual result was $1.0 million, down 60.13% from the prior year.
• Other Operating Expenses came in at $210016.0 for Q1 2026 at RetinalGenix Technologies, down from $281246.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $2.1 million in Q3 2022 to a low of $55051.0 in Q1 2022.
• The 5-year median for Other Operating Expenses is $231933.0 (2025), against an average of $400987.8.
• Across the five-year window, Other Operating Expenses jumped 3721.14% in 2022 and plunged 86.62% in 2025, its largest moves.
• RetinalGenix Technologies' Other Operating Expenses stood at $78509.0 in 2022, then fell by 0.0% to $78507.0 in 2023, then surged by 370.9% to $369687.0 in 2024, then decreased by 23.92% to $281246.0 in 2025, then retreated by 25.33% to $210016.0 in 2026.
• The last three Other Operating Expenses figures came in at $210016.0 (Q1 2026), $281246.0 (Q4 2025), and $277226.0 (Q3 2025), per Business Quant data.